Report Summary
It is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed.
The global Tavaborole market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2027, growing at a CAGR of xx% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Tavaborole market based on company, product type, end user and key regions.
This report studies the global market size of Tavaborole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tavaborole in these regions.
This research report categorizes the global Tavaborole market by top players/brands, region, type and end user. This report also studies the global Tavaborole market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
VIRUJ Pharmaceutical
Wavelength
Hovione
Market size by Product
Purity ? 98%
Purity ? 98%
Market size by End User
Onychomycosis
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Tavaborole market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Tavaborole market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tavaborole companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tavaborole submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Tavaborole are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tavaborole market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Tavaborole Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tavaborole Market Size Growth Rate by Product
1.4.2 Purity ? 98%
1.4.3 Purity ? 98%
1.5 Market by End User
1.5.1 Global Tavaborole Market Size Growth Rate by End User
1.5.2 Onychomycosis
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tavaborole Market Size
2.1.1 Global Tavaborole Revenue 2017-2027
2.1.2 Global Tavaborole Sales 2017-2027
2.2 Tavaborole Growth Rate by Regions
2.2.1 Global Tavaborole Sales by Regions
2.2.2 Global Tavaborole Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Tavaborole Sales by Manufacturers
3.1.1 Tavaborole Sales by Manufacturers
3.1.2 Tavaborole Sales Market Share by Manufacturers
3.1.3 Global Tavaborole Market Concentration Ratio (CR5 and HHI)
3.2 Tavaborole Revenue by Manufacturers
3.2.1 Tavaborole Revenue by Manufacturers (2017-2020)
3.2.2 Tavaborole Revenue Share by Manufacturers (2017-2020)
3.3 Tavaborole Price by Manufacturers
3.4 Tavaborole Manufacturing Base Distribution, Product Types
3.4.1 Tavaborole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tavaborole Product Type
3.4.3 Date of International Manufacturers Enter into Tavaborole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Tavaborole Sales by Product
4.2 Global Tavaborole Revenue by Product
4.3 Tavaborole Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Tavaborole Breakdown Data by End User
6 North America
6.1 North America Tavaborole by Countries
6.1.1 North America Tavaborole Sales by Countries
6.1.2 North America Tavaborole Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tavaborole by Product
6.3 North America Tavaborole by End User
7 Europe
7.1 Europe Tavaborole by Countries
7.1.1 Europe Tavaborole Sales by Countries
7.1.2 Europe Tavaborole Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tavaborole by Product
7.3 Europe Tavaborole by End User
8 Asia Pacific
8.1 Asia Pacific Tavaborole by Countries
8.1.1 Asia Pacific Tavaborole Sales by Countries
8.1.2 Asia Pacific Tavaborole Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tavaborole by Product
8.3 Asia Pacific Tavaborole by End User
9 Central & South America
9.1 Central & South America Tavaborole by Countries
9.1.1 Central & South America Tavaborole Sales by Countries
9.1.2 Central & South America Tavaborole Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tavaborole by Product
9.3 Central & South America Tavaborole by End User
10 Middle East and Africa
10.1 Middle East and Africa Tavaborole by Countries
10.1.1 Middle East and Africa Tavaborole Sales by Countries
10.1.2 Middle East and Africa Tavaborole Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tavaborole by Product
10.3 Middle East and Africa Tavaborole by End User
11 Company Profiles
11.1 VIRUJ Pharmaceutical
11.1.1 VIRUJ Pharmaceutical Company Details
11.1.2 Company Business Overview
11.1.3 VIRUJ Pharmaceutical Tavaborole Sales, Revenue and Gross Margin (2017-2020)
11.1.4 VIRUJ Pharmaceutical Tavaborole Products Offered
11.1.5 VIRUJ Pharmaceutical Recent Development
11.2 Wavelength
11.2.1 Wavelength Company Details
11.2.2 Company Business Overview
11.2.3 Wavelength Tavaborole Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Wavelength Tavaborole Products Offered
11.2.5 Wavelength Recent Development
11.3 Hovione
11.3.1 Hovione Company Details
11.3.2 Company Business Overview
11.3.3 Hovione Tavaborole Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Hovione Tavaborole Products Offered
11.3.5 Hovione Recent Development
12 Future Forecast
12.1 Tavaborole Market Forecast by Regions
12.1.1 Global Tavaborole Sales Forecast by Regions 2021-2027
12.1.2 Global Tavaborole Revenue Forecast by Regions 2021-2027
12.2 Tavaborole Market Forecast by Product
12.2.1 Global Tavaborole Sales Forecast by Product 2021-2027
12.2.2 Global Tavaborole Revenue Forecast by Product 2021-2027
12.3 Tavaborole Market Forecast by End User
12.4 North America Tavaborole Forecast
12.5 Europe Tavaborole Forecast
12.6 Asia Pacific Tavaborole Forecast
12.7 Central & South America Tavaborole Forecast
12.8 Middle East and Africa Tavaborole Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tavaborole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
